Biomarkers in Lung Cancer Screening: the Importance of Study Design

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2021 Jan 15

PMID 33446580

Citations 6

Authors

David R Baldwin

Matthew E Callister

Philip A Crosbie

Emma L ODowd

Robert C Rintoul

Hilary A Robbins

Robert J C Steele

Affiliations

Soon will be listed here.

Citing Articles

Five year mortality in an RCT of a lung cancer biomarker to select people for low dose CT screening.

Sullivan F, Mair F, Anderson W, Chew C, Dorward A, Haughney J PLoS One. 2025; 20(1):e0306163.

PMID: 39774508 PMC: 11709295. DOI: 10.1371/journal.pone.0306163.

Assessing the 9G Technology Blood Test for Predicting Lung Cancer in Patients with CT-Detected Lung Nodules: A Multicenter Clinical Trial.

Kim S, Park Y, Kim I, Kim H, Lee K Cancers (Basel). 2024; 16(22).

PMID: 39594693 PMC: 11593157. DOI: 10.3390/cancers16223737.

Health Economic Evaluation of Lung Cancer Screening Using a Diagnostic Blood Test: The Early Detection of Cancer of the Lung Scotland (ECLS).

Robles-Zurita J, McMeekin N, Sullivan F, Mair F, Briggs A Curr Oncol. 2024; 31(6):3546-3562.

PMID: 38920744 PMC: 11202544. DOI: 10.3390/curroncol31060261.

The Role of Biomarkers in Lung Cancer Screening.

Boutsikou E, Hardavella G, Fili E, Bakiri A, Gaitanakis S, Kote A Cancers (Basel). 2024; 16(11).

PMID: 38893101 PMC: 11171002. DOI: 10.3390/cancers16111980.

Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.

Lam S, Bai C, Baldwin D, Chen Y, Connolly C, de Koning H J Thorac Oncol. 2023; 19(1):36-51.

PMID: 37487906 PMC: 11253723. DOI: 10.1016/j.jtho.2023.07.019.

References

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

Becker N, Motsch E, Trotter A, Heussel C, Dienemann H, Schnabel P . Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial. Int J Cancer. 2019; 146(6):1503-1513. DOI: 10.1002/ijc.32486. View

de Koning H, van der Aalst C, de Jong P, Scholten E, Nackaerts K, Heuvelmans M . Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020; 382(6):503-513. DOI: 10.1056/NEJMoa1911793. View

Field J, Duffy S, Baldwin D, Whynes D, Devaraj A, Brain K . UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax. 2015; 71(2):161-70. PMC: 4752629. DOI: 10.1136/thoraxjnl-2015-207140. View

Liu M, Oxnard G, Klein E, Swanton C, Seiden M . Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2021; 31(6):745-759. PMC: 8274402. DOI: 10.1016/j.annonc.2020.02.011. View

Lennon A, Buchanan A, Kinde I, Warren A, Honushefsky A, Cohain A . Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science. 2020; 369(6499). PMC: 7509949. DOI: 10.1126/science.abb9601. View

Ten Haaf K, van Rosmalen J, de Koning H . Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. Cancer Epidemiol Biomarkers Prev. 2014; 24(1):154-61. PMC: 4357842. DOI: 10.1158/1055-9965.EPI-14-0745. View

Tammemagi M, Schmidt H, Martel S, McWilliams A, Goffin J, Johnston M . Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Lancet Oncol. 2017; 18(11):1523-1531. DOI: 10.1016/S1470-2045(17)30597-1. View

Marquette C, Boutros J, Benzaquen J, Ferreira M, Pastre J, Pison C . Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study. Lancet Respir Med. 2020; 8(7):709-716. DOI: 10.1016/S2213-2600(20)30081-3. View

10.

Gressel G, Maggi E, Harmon B, Ye K, Kuo D, Dolan S . Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer. J Transl Med. 2020; 18(1):323. PMC: 7457235. DOI: 10.1186/s12967-020-02493-8. View

11.

Cohen J, Li L, Wang Y, Thoburn C, Afsari B, Danilova L . Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018; 359(6378):926-930. PMC: 6080308. DOI: 10.1126/science.aar3247. View

12.

Ten Haaf K, Jeon J, Tammemagi M, Han S, Kong C, Plevritis S . Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. PLoS Med. 2017; 14(4):e1002277. PMC: 5380315. DOI: 10.1371/journal.pmed.1002277. View

13.

. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial. J Thorac Oncol. 2019; 14(10):1732-1742. PMC: 6764895. DOI: 10.1016/j.jtho.2019.05.044. View

14.

Sullivan F, Mair F, Anderson W, Armory P, Briggs A, Chew C . Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. Eur Respir J. 2020; 57(1). PMC: 7806972. DOI: 10.1183/13993003.00670-2020. View

15.

Paci E, Puliti D, Pegna A, Carrozzi L, Picozzi G, Falaschi F . Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017; 72(9):825-831. DOI: 10.1136/thoraxjnl-2016-209825. View

16.

Mazzone P, Silvestri G, Patel S, Kanne J, Kinsinger L, Wiener R . Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018; 153(4):954-985. DOI: 10.1016/j.chest.2018.01.016. View

17.

Chabon J, Hamilton E, Kurtz D, Esfahani M, Moding E, Stehr H . Integrating genomic features for non-invasive early lung cancer detection. Nature. 2020; 580(7802):245-251. PMC: 8230734. DOI: 10.1038/s41586-020-2140-0. View

18.

Yuxia M, Zhennan T, Wei Z . Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol. 2012; 138(12):2045-50. DOI: 10.1007/s00432-012-1285-0. View

19.

Shen S, Singhania R, Fehringer G, Chakravarthy A, Roehrl M, Chadwick D . Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature. 2018; 563(7732):579-583. DOI: 10.1038/s41586-018-0703-0. View

20.

Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud J, Padovani B . "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One. 2014; 9(10):e111597. PMC: 4216113. DOI: 10.1371/journal.pone.0111597. View